Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration
<!--[if gte mso 9]><xml> Normal 0 false false false MicrosoftInternetExplorer4 </xml><![endif]--><!--[if gte mso 9]><xml> </xml><![endif]--> <!--[if gte mso 10]> <styl...
Main Authors: | Mehdi Modarreszadeh, Masood Naseripour, Khalil Ghasemi-Falavarjani, Aminollah Nikeghbali, Masih Hashemi, Mohammad-Mehdi Parvaresh |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2008-12-01
|
Series: | Journal of Ophthalmic & Vision Research |
Online Access: | http://www.jovr.ir/index.php/jovr/article/view/35 |
Similar Items
-
Intravitreal Bevacizumab for Pseudophakic Cystoid Macular Edema; a Systematic Review
by: Khalil Ghasemi Falavarjani, et al.
Published: (2012-01-01) -
Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
by: Elad Moisseiev, et al.
Published: (2010-08-01) -
Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01) -
Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
by: Partha Biswas, et al.
Published: (2011-01-01) -
Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration
by: Cihan Ünlü, et al.
Published: (2015-08-01)